Average Co-Inventor Count = 2.00
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Iovance Biotherapeutics, Inc. (8 from 96 patents)
8 patents:
1. 12495791 - CLOSED PROCESS FOR EXPANSION AND GENE EDITING OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
2. 12104172 - Processes for generating TIL products enriched for tumor antigen-specific t-cells
3. 12031157 - Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
4. 12024718 - Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
5. 11866688 - Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
6. 11713446 - Processes for generating TIL products enriched for tumor antigen-specific T-cells
7. 11384337 - Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
8. 11357841 - Expansion of tumor infiltrating lymphocytes with potassium channel agonists and therapeutic uses thereof